Literature DB >> 17022701

Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain.

E Rey1, C Moreno Elola-Olaso, F Rodríguez Artalejo, M Díaz-Rubio.   

Abstract

OBJECTIVES: To estimate the impact of gastroesophageal reflux (GER) symptoms on the utilization of healthcare services and work absenteeism in Spain.
METHODS: A cross-sectional study on 2,500 subjects representative of the Spanish population from 40 to 79 years of age. Data were collected via a telephone interview in January 2002 using Locke s questionnaire after its cross-cultural adaptation and validation for telephone use in Spain.
RESULTS: GER is responsible for 296.8 doctor consultations (95% CI: 245.3-348.7) per 1,000 inhabitants per year, for 24 esophagogastrointestinal radiographic studies per 1,000 inhabitants per year (95% CI: 18-30), for 32.4 (95% CI: 25.5-39.3) high digestive endoscopies per 1,000 inhabitants per year, and for the loss of 201 (95% CI: 0-411.1) working days per 1,000 employed inhabitants with GER per year. In relation to medication intake, GER resulted in 4,092 (95% CI: 3,300-5,133) treatment days with H2 antagonists per 1,000 inhabitants per year, 9,030 (95% CI: 7,846-10,332) treatment days with proton pump inhibitors per 1,000 inhabitants per year, and 1,082 (95% CI: 519-1,549) treatment days with prokinetics per 1,000 inhabitants per year.
CONCLUSIONS: GER has a large impact on the utilization of healthcare resources and work absenteeism in Spain, in contrast to the widespread belief that it is an illness of little importance.

Entities:  

Mesh:

Year:  2006        PMID: 17022701     DOI: 10.4321/s1130-01082006000700005

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  3 in total

1.  [Use of health resources and loss of productivity in gastroesophageal reflux disease: results of a cross-sectional study in a primary care setting in Spain].

Authors:  Javier Nuevo; Mónica Tafalla; Javier Zapardiel; J P Gisbert
Journal:  Aten Primaria       Date:  2011-03-05       Impact factor: 1.137

2.  Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists.

Authors:  Fermín Mearin; Julio Ponce; Marta Ponce; Agustín Balboa; Miguel A González; Javier Zapardiel
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

3.  Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany.

Authors:  M Gross; U Beckenbauer; J Burkowitz; H Walther; B Brueggenjuergen
Journal:  Eur J Med Res       Date:  2010-03-30       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.